The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
Open accessAbstract
OBJECTIVE: To perform a systematic literature review of the long-term safety of methotrexate (MTX) monotherapy in rheumatoid arthritis (RA). METHODS: A search was performed in Medline, Cochrane and EMBASE. Adults with RA who had received MTX monotherapy for more than 2 years were studied. RESULTS: 88 published studies were included. Over 12 years of treatment, the termination rate of MTX due to toxicity was less than for sulfasalazine, gold, d-penicillamine and higher than for hydroxychloroquine (level of evidence 2a-2b). Long-term use of MTX does not appear to be a risk factor for serious infections, including herpes zoster (2b-4), and could provide a survival benefit by reducing cardiovascular mortality (2b). The prevalence of raised liver enzymes (more than twice the upper limit of normal) is close to 13% of patients; 3.7% of patients stopped MTX permanently owing to liver toxicity (2b). Data on the risk for liver fibrosis/cirrhosis are conflicting: a meta-analysis showed an incidence of fibrosis of 2.7% after 4 years of MTX (2a). However, two other studies on sequential liver biopsies did not show evidence for developing severe damage (2b). Insufficient data are available to fully assess the risk of lymphoma and malignancies, although there is no strong evidence of increased risk (2b-4). CONCLUSION: This systematic literature search on MTX monotherapy with relatively low-dose use during at least 2 years shows favourable long-term safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Combe, B., Landewe, R., Lukas, C., Bolosiu, H. D., Breedveld, F., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044354 · Cited by 786
Wolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Predictors of infection in rheumatoid arthritis
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10529 · Cited by 560
Visser, K., Katchamart, W., Loza, E., Martinez-Lopez, J. A., Salliot, C., Trudeau, J., Bombardier, C., Carmona, L., van der Heijde, D., Bijlsma, J. W. J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094474 · Cited by 491
Self-citationMariette, X. (2002) · Blood · doi:10.1182/blood.v99.11.3909 · Cited by 428
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
Kremer, J. M., & Lee, J. K. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290702 · Cited by 360
Methotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80060-9 · Cited by 358
Shea, B., Swinden, M. V., Tanjong Ghogomu, E., Ortiz, Z., Katchamart, W., Rader, T., Bombardier, C., Wells, G. A., & Tugwell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951.pub2 · Cited by 347
Methotrexate in Rheumatoid Arthritis
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-418 · Cited by 345
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis
Gutierrez‐Ureña, S., Molina, J. F., García, C. O., Cuéllar, M. L., & Espinoza, L. R. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390214 · Cited by 279
van Halm, V. P., Nurmohamed, M. T., Twisk, J. W., Dijkmans, B. A., & Voskuyl, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2045 · Cited by 267
Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis
Weinblatt, M. E., Trentham, D. E., Fraser, P. A., Holdsworth, D. E., Falchuk, K. R., Weissman, B. N., & Coblyn, J. S. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310203 · Cited by 229
Walker, A. M., Funch, D., Dreyer, N. A., Tolman, K. G., Kremer, J. M., Alarcón, G. S., Lee, R. G., & Weinblatt, M. E. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360307 · Cited by 206
Kremer, J. M., Lee, R. G., & Tolman, K. G. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320202 · Cited by 199
Kamel, O. W., van de Rijn, M., LeBrun, D. P., Weiss, L. M., Warnke, R. A., & Dorfman, R. F. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90295-x · Cited by 185
Maetzel, A., Wong, A., Strand, V., Tugwell, P., Wells, G., & Bombardier, C. (2000) · Rheumatology · doi:10.1093/rheumatology/39.9.975 · Cited by 184
Methotrexate therapy in rheumatoid arthritis: 15 years experience
Hoffmeister, R. T. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90477-1 · Cited by 177
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
Landewe, R. B., van den Borne, B. E., Breedveld, F. C., & Dijkmans, B. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02222-4 · Cited by 158
Wolfe, F., Michaud, K. D., & Chakravarty, E. F. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel328 · Cited by 153
Perhala, R. S., Wilke, W. S., Clough, J. D., & Segal, A. M. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340204 · Cited by 138
Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis
Franklin, J. P., Lunt, M., Bunn, D. K., Symmons, D. P. M., & Silman, A. J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044784 · Cited by 134
Infections during low-dose methotrexate treatmentin rheumatoid arthritis
Boerbooms, A. M. T., Kerstens, P. J. S. M., van Loenhout, J. W. A., et al. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80009-3 · Cited by 118
Methotrexate and Hepatic Toxicity in??Rheumatoid Arthritis and Psoriatic Arthritis
Tilling, L., Townsend, S., & David, J. (2006) · Clinical Drug Investigation · doi:10.2165/00044011-200626020-00001 · Cited by 114
Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations
Weinstein, A., Marlowe, S., Korn, J. H., et al. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90312-2 · Cited by 110
Shergy, W. J., Polisson, R. P., Caldwell, D. S., Rice, J. R., Pisetsky, D. S., & Allen, N. B. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80019-6 · Cited by 107
Kremer, J. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400533 · Cited by 100
Kent, P. D., Luthra, H. S., & Michet, C. J. (2004) · PubMed · Cited by 94
A toxicity index for comparison of side effects among different drugs
Fries, J. F., Spitz, P. W., Williams, C. A., Bloch, D. A., Singh, G., & Hubert, H. B. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330117 · Cited by 91
Fürst, D. E., Erikson, N., Clute, L., Koehnke, R., Burmeister, L. F., & Kohler, J. A. (1990) · PubMed · Cited by 89
Aponte, J., & Petrelli, M. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311201 · Cited by 79
Aletaha, D., Stamm, T., Kapral, T., Eberl, G., Grisar, J., Machold, K. P., & Smolen, J. S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.10.944 · Cited by 79
Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate
Bologna, C., Picot, M.-C., Jørgensen, C., et al. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.2.97 · Cited by 54
Cardiovascular disease in rheumatoid arthritis: Single-center hospital-based cohort study in France
Assous, N., Touzé, E., Meune, C., Kahan, A., & Allanore, Y. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.10.001 · Cited by 53
Ros, S., Juanola, X., Condom, E., Cañas, C., Riera, J., Guardiola, J., Blanco-Barnusell, J. D., Rebasa, P., Valverde, J., & Roig-Escofet, D. (2002) · Scandinavian Journal of Rheumatology · doi:10.1080/030097402320817040 · Cited by 35
Újfalussy, I., Ko�, �., Seszt�k, M., & Gergely, P. (2003) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-003-0458-2 · Cited by 30
Salaffi, F., Carotti, M., Sartini, A., et al. (1995) · PubMed · Cited by 29
Cited by
Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
Smolen, J. S., Landewé, R., Breedveld, F. C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,763
Self-citationDougados, M., Soubrier, M., Antunez, A., Balint, P., Balsa, A., Buch, M. H., Casado, G., Detert, J., El-zorkany, B., Emery, P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204223 · Cited by 855
Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Metadata
- Authors
- Salliot, C., & van der Heijde, D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 68
- Issue
- 7
- Pages
- 1100-1104
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2133103918
- Cited by
- 673
- References
- 39
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.